Parallax Volatility Advisers, L.P. - RAPTOR PHARMACEUTICAL CORP ownership

Quarter-by-quarter ownership
Parallax Volatility Advisers, L.P. ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q3 2016$240,000
-44.3%
26,775
-66.6%
0.00%
-100.0%
Q2 2016$431,000
-14.0%
80,275
-26.3%
0.00%0.0%
Q1 2016$501,000
-55.0%
108,975
-49.1%
0.00%
-50.0%
Q4 2015$1,113,000
+9.2%
213,975
+26.9%
0.00%0.0%
Q3 2015$1,019,000
+10.2%
168,575
+187.8%
0.00%0.0%
Q2 2015$925,00058,5750.00%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q4 2016
NameSharesValueWeighting ↓
Trellus Management Company, LLC 63,500$1,003,0001.13%
Broadfin Capital, LLC 1,319,883$20,841,0001.12%
BAILARD, INC. 160,000$2,526,0000.39%
Birchview Capital, LP 46,000$726,0000.38%
HIGHLAND CAPITAL MANAGEMENT LP 1,182,167$18,666,0000.38%
Rock Springs Capital Management LP 305,000$4,816,0000.35%
SPHERA FUNDS MANAGEMENT LTD. 206,500$3,261,0000.32%
GLOBEFLEX CAPITAL L P 109,771$1,733,0000.32%
GROUP ONE TRADING, L.P. 1,319,766$20,839,0000.29%
Perceptive Advisors 264,204$4,172,0000.25%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders